Caricamento...
Patient‐reported outcomes in a study of human regular U‐500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes
Human regular U‐500 insulin (U‐500R) provides both basal and prandial coverage to people with diabetes. As part of the VIVID study, we studied patient‐reported outcomes (PRO) of U‐500R delivered by multiple daily injections (MDI, n = 211) and continuous subcutaneous infusion using a novel U‐500R pum...
Salvato in:
| Pubblicato in: | Diabetes Obes Metab |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Blackwell Publishing Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756478/ https://ncbi.nlm.nih.gov/pubmed/32893428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14191 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|